```html

Saddle Anemia – A Complete Patient‑Friendly Guide

Overview

Saddle anemia is a descriptive term used by hematologists to characterize a distinct pattern of moderate‑to‑severe iron‑deficiency anemia that results from chronic, low‑grade blood loss in the “saddle” region of the gastrointestinal (GI) tract—specifically the distal duodenum and proximal jejunum where angiodysplastic lesions or small ulcers commonly occur. The name derives from the “saddle” appearance of the mucosal blood‑vessel network seen on endoscopy.

Although the condition is relatively uncommon, it is increasingly recognized in the following populations:

• Adults > 50 years of age (≈ 2–3 % of the general population over 60).
• Patients with chronic kidney disease (CKD) on dialysis (up to 15 % develop saddle‑type iron‑deficiency anemia).
• Individuals on long‑term non‑steroidal anti‑inflammatory drugs (NSAIDs) or antiplatelet agents.
• Patients with hereditary hemorrhagic telangiectasia (HHT) or other vascular malformations.

Overall, anemia affects roughly 24 % of all adults worldwide (World Health Organization, 2022), and saddle anemia accounts for an estimated 5–7 % of all iron‑deficiency cases in high‑income countries.

Symptoms

Symptoms arise from reduced oxygen‑carrying capacity of the blood and, occasionally, from the underlying GI pathology. They can be subtle at first and progress gradually.

General anemia‑related symptoms

• Fatigue & weakness – a pervasive lack of energy that does not improve with rest.
• Dyspnea on exertion – shortness of breath after climbing stairs or walking a short distance.
• Pallor – noticeably pale skin, especially on the face, nail beds, and inner eyelids.
• Headache & dizziness – may be more pronounced when standing quickly (orthostatic dizziness).
• Palpitations – feeling of a racing or irregular heartbeat.
• Cold extremities – hands and feet feel unusually cold.

GI‑specific symptoms (reflecting the “saddle” source of bleeding)

• Occult or intermittent melena – dark, tarry stools that may be noticed only on a stool‑guaiac test.
• Occasional painless hematochezia – bright red blood on the toilet paper, often missed by the patient.
• Epigastric discomfort – mild cramping or burning that does not respond to antacids.
• Unexplained weight loss – due to chronic GI irritation.
• Iron‑deficiency specific signs – brittle nails (koilonychia) and a sore tongue (glossitis).

Causes and Risk Factors

Saddle anemia is essentially iron‑deficiency anemia caused by chronic, low‑volume GI blood loss that is difficult to detect without targeted investigation.

Primary causes

• Angiodysplasia of the duodenum/jejunum – dilated, fragile blood vessels that bleed intermittently.
• Small‑bowel ulcers – often related to NSAID use, Helicobacter pylori infection, or ischemia.
• Vascular malformations in hereditary hemorrhagic telangiectasia (HHT).
• Radiation enteritis – chronic mucosal injury after abdominal radiotherapy.

Risk factors

• Age > 50 years.
• Chronic kidney disease or dialysis dependence.
• Long‑term NSAID, aspirin, or anticoagulant therapy.
• History of GI surgery (especially gastric bypass or bowel resection).
• Genetic predisposition to vascular malformations (e.g., HHT).
• Alcohol abuse (increases mucosal irritation).
• Low dietary iron intake (vegetarian/vegan diets without supplementation).

Diagnosis

Diagnosing saddle anemia requires confirming iron‑deficiency anemia first, then locating the occult GI source.

Initial laboratory work‑up

• Complete Blood Count (CBC) – low hemoglobin (Hb) and hematocrit, low mean corpuscular volume (MCV) indicating microcytic anemia.
• Serum ferritin – low (< 30 ng/mL) is the most sensitive marker of iron deficiency.
• Serum iron, total iron‑binding capacity (TIBC), transferrin saturation – low iron, high TIBC, low saturation (< 15 %).
• Reticulocyte count – usually low or inappropriately normal.
• Optional: Vitamin B12 & folate – to rule out mixed deficiencies.

Stool tests

• Fecal occult blood test (FOBT) or fecal immunochemical test (FIT) – positive in > 80 % of saddle anemia cases.
• Stool ova & parasite panel – if travel history suggests infectious cause.

Imaging and endoscopic evaluation

1. Upper endoscopy (EGD) – visualizes duodenum; often the first step.
2. Push enteroscopy or balloon‑assisted enteroscopy – allows direct inspection of the proximal jejunum where the “saddle” lesions reside.
3. Capsule endoscopy – non‑invasive way to view the entire small bowel; diagnostic yield > 70 % for angiodysplasia.
4. CT enterography or MR enterography – identifies vascular malformations or masses if endoscopy is inconclusive.

Pathology (if lesions are biopsied)

Histology typically shows bland mucosa with dilated submucosal capillaries; no dysplasia or malignancy in pure saddle anemia.

Treatment Options

Treatment is two‑pronged: correct the iron deficit and stop the bleeding source.

Iron replacement

• Oral ferrous sulfate – 325 mg (≈ 65 mg elemental iron) 2–3 times daily; a 3–6‑month course with re‑check of ferritin.
• Alternative oral formulations – ferrous gluconate, ferrous fumarate, or newer ferric maltol (30 mg elemental iron) for better tolerability.
• Intravenous iron – preferred when oral absorption is impaired (CKD, inflammation) or rapid repletion is needed. Common agents: iron sucrose (200 mg per dose) or ferric carboxymaltose (up to 1000 mg single infusion).

Addressing the bleeding source

1. Endoscopic therapy – argon plasma coagulation (APC) or bipolar cautery to ablate angiodysplastic lesions.
2. Pharmacologic agents
   • **Tranexamic acid** 1 g PO q6h for short courses (up to 7 days) can reduce bleeding.
   • **Octreotide** long‑acting monthly injection (20 mg) for refractory vascular lesions.
3. Surgical resection – reserved for focal lesions not amenable to endoscopy.
4. Adjustment of medications – discontinue or substitute NSAIDs/anticoagulants if possible.

Lifestyle and dietary measures

• Increase intake of heme‑iron foods (red meat, poultry, fish) and non‑heme iron with vitamin C (citrus fruits, peppers).
• Avoid coffee/tea at meals, as they inhibit iron absorption.
• Limit alcohol and spicy foods that can aggravate mucosal lesions.

Living with Saddle Anemia

Even after the bleeding source is treated, ongoing management helps prevent recurrence.

Daily self‑care tips

• Take iron supplements on an empty stomach with a glass of water; if GI upset occurs, pair with a small amount of food.
• Schedule a short 30‑minute walk most days to boost circulation and energy.
• Monitor stool color; any new melena or bright red blood should prompt a call to your clinician.
• Keep a symptom diary (fatigue level, heart rate, any GI discomfort) to share at follow‑up visits.

Follow‑up schedule

• First CBC and ferritin check 4–6 weeks after initiating therapy.
• Repeat endoscopic evaluation if symptoms persist after 3 months.
• Annual assessment for high‑risk patients (CKD, chronic NSAID use).

Prevention

Because the underlying issue is chronic low‑grade bleeding, primary prevention focuses on protecting the GI mucosa and maintaining adequate iron stores.

• Use the lowest effective dose of NSAIDs or switch to acetaminophen when possible.
• For patients requiring anticoagulation, discuss dose adjustments or alternative agents (e.g., direct oral anticoagulants with lower GI bleed risk).
• Screen high‑risk groups (CKD, HHT) with periodic fecal occult blood testing.
• Adopt an iron‑rich diet and consider routine iron supplementation for vegans or patients with known low ferritin (< 30 ng/mL).
• Control comorbidities that increase bleeding risk, such as hypertension and uncontrolled diabetes.

Complications

If left untreated, saddle anemia can lead to serious health problems.

• Cardiovascular strain – chronic anemia forces the heart to pump more blood, potentially causing left‑ventricular hypertrophy or heart failure.
• Severe fatigue and reduced quality of life – limiting work, exercise, and daily activities.
• Pregnancy‑related issues – maternal anemia increases risk of preterm birth, low birth weight, and postpartum hemorrhage.
• Increased susceptibility to infections – iron is essential for immune function.
• Progression to overt GI bleeding – small lesions can enlarge or multiply, leading to acute hemorrhage.

When to Seek Emergency Care

References

• Mayo Clinic. “Iron‑deficiency anemia.” Updated 2023. https://www.mayoclinic.org/diseases-conditions/iron-deficiency-anemia
• World Health Organization. “Worldwide prevalence of anemia 1993–2021.” WHO Report, 2022.
• National Institutes of Health – National Heart, Lung, and Blood Institute. “Anemia of Chronic Disease.” 2024.
• Cleveland Clinic. “Angiodysplasia of the Small Intestine.” 2023.
• American College of Gastroenterology. “Guidelines for Diagnosis and Management of Small‑Bowel Bleeding.” Gastroenterology 2022;162(5):1245‑1257.
• CDC. “Guidelines for Fecal Occult Blood Testing.” 2023.

```